134 related articles for article (PubMed ID: 1835012)
21. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
22. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
[TBL] [Abstract][Full Text] [Related]
23. [Recall of the importance of serological monitoring of children with suspected congenital toxoplasmosis].
Pujol M; Malbruny B; Morel C; Exmelin L
Pathol Biol (Paris); 1992 Mar; 40(3):238-41. PubMed ID: 1608667
[TBL] [Abstract][Full Text] [Related]
24. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
25. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
[TBL] [Abstract][Full Text] [Related]
26. [Toxoplasmosis in pregnancy: prevention, prenatal diagnosis and treatment].
Hohlfeld P; Biedermann K; Extermann P; Gyr T
Schweiz Med Wochenschr Suppl; 1995; 65():62S-69S. PubMed ID: 7716455
[TBL] [Abstract][Full Text] [Related]
27. Treatment of toxoplasmosis in the pregnant mother and newborn child.
Stray-Pedersen B
Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
[TBL] [Abstract][Full Text] [Related]
28. [Monitoring and treatment of toxoplasmosis in the pregnant woman, fetus and newborn].
Garin JP; Mojon M; Piens MA; Chevalier-Nuttall I
Pediatrie; 1989; 44(9):705-12. PubMed ID: 2695891
[TBL] [Abstract][Full Text] [Related]
29. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
[TBL] [Abstract][Full Text] [Related]
31. [The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
Lässker G; Degen R; Keller J
Z Kinderheilkd; 1969; 105(2):132-41. PubMed ID: 5813227
[No Abstract] [Full Text] [Related]
32. [Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
Mirlesse V; Jacquemard F; Daffos F
Presse Med; 1993 Feb; 22(6):258-62. PubMed ID: 8511144
[TBL] [Abstract][Full Text] [Related]
33. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid.
Gratzl R; Sodeck G; Platzer P; Jäger W; Graf J; Pollak A; Thalhammer T
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):12-6. PubMed ID: 11913495
[TBL] [Abstract][Full Text] [Related]
34. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
35. Results of a preventive program for congenital toxoplasmosis.
Ghidini A; Sirtori M; Spelta A; Vergani P
J Reprod Med; 1991 Apr; 36(4):270-3. PubMed ID: 2072359
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of children with congenital toxoplasmosis.
Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis of congenital infection].
Sampedro Martínez A; Martínez LA; Teatino PM; Rodríguez-Granger J
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():15-20. PubMed ID: 22305665
[TBL] [Abstract][Full Text] [Related]
38. [Prenatal diagnosis of congenital toxoplasmosis].
Taglioretti A; Vucetich A; Agostoni G; Ravizza M; Meroni V; Semprini AG; Pardi G
Ann Ostet Ginecol Med Perinat; 1989; 110(1):49-54. PubMed ID: 2757328
[TBL] [Abstract][Full Text] [Related]
39. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
40. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis.
Fricker-Hidalgo H; Brenier-Pinchart MP; Schaal JP; Equy V; Bost-Bru C; Pelloux H
Pediatr Infect Dis J; 2007 Sep; 26(9):845-6. PubMed ID: 17721384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
